Skip to main content

Table 1 Yearly population-adjusted prescription volume and costs of antineoplastic agents by region (2009-2012)

From: Geographic Variations and Time Trends in Cancer Treatments in Taiwan

Region

Year

Population

Prescription volume and cost of targeted therapies and all antineoplastic agents

Number of prescriptions of TT

Number of prescriptions of all antineoplastic agents

Population adjusted prescription volume of TT per 100,000 people

Population adjusted prescription volume of all antineoplastic agents per 100,000 people

Cost of TT (US$)

Cost of all antineoplastic agents (US$)

Population adjusted Cost of TT per 100,000 people

Population adjusted Cost of all antineoplastic agents per 100,000 people

Northern

2009

10,794,022

41,563

1,200,447

385.06

11,121.41

44,727,732.83

245,327,405.57

414,375

2,272,808

2010

10,852,146

53,085

1,352,126

489.17

12,459.53

64,066,867.43

298,340,256.13

590,361

2,749,136

2011

10,919,415

74,409

1,539,869

681.44

14,102.12

80,098,867.07

335,228,189.63

733,545

3,070,020

2012

10,991,480

107,447

1,681,041

977.55

15,294.04

108,328,729.00

369,543,104.87

985,570

3,362,087

Midwestern

2009

5,201,847

16,182

517,142

311.08

9,941.51

17,550,734.80

105,008,551.23

337,394

2,018,678

2010

5,199,849

22,116

587,463

425.32

11,297.69

25,919,867.20

130,844,276.37

498,473

2,516,309

2011

5,203,796

28,424

641,058

546.22

12,319.05

31,768,038.03

148,131,812.10

610,478

2,846,611

2012

5,215,948

41,136

691,949

788.66

13,266.03

45,052,172.70

168,569,414.17

863,739

3,231,808

Southern

2009

6,446,720

26,808

735,122

415.84

11,403.04

27,431,583.03

143,013,766.23

425,512

2,218,396

2010

6,433,342

33,836

834,331

525.95

12,968.86

37,988,591.17

178,074,087.10

590,495

2,767,987

2011

6,422,584

45,262

904,722

704.73

14,086.57

48,387,511.27

201,906,589.30

753,396

3,143,697

2012

6,422,531

65,905

983,272

1,026.15

15,309.73

66,284,538.63

223,610,506.80

1,032,063

3,481,657

Eastern

2009

573,461

1,255

52,193

218.85

9,101.40

1,872,531.70

9,729,753.87

326,532

1,696,672

2010

569,478

1,736

60,197

304.84

10,570.56

2,248,463.80

12,178,410.27

394,829

2,138,522

2011

565,128

2,415

66,179

427.34

11,710.44

2,951,519.27

14,101,363.17

522,274

2,495,251

2012

561,442

3,047

68,875

542.71

12,267.52

3,493,181.90

14,396,745.00

622,180

2,564,244

Outer Islands

2009

103,722

1

2,431

0.96

2,343.77

53.30

170,837.17

51

164,707

2010

107,308

0

3,261

0.00

3,038.92

0.00

316,458.37

0

294,907

2011

113,989

1

3,654

0.88

3,205.57

649.13

387,676.10

569

340,100

2012

124,421

26

4,539

20.90

3,648.10

17,180.40

481,334.53

13,808

386,860

  1. TT targeted therapies; Population adjusted prescription volume = Number of prescriptions / Population, per 100,000 people; Population adjusted costs = Cost / Population, per 100,000 people